Assessment of antimicrobial consumption in food animals in Dar es Salaam, Tanzania

Abstract

Monitoring antimicrobial use in food-producing animals is one of the global strategies to tackle antimicrobial resistance. The purpose of the present study is to generate quantitative information on antimicrobial use pattern in Dar es Salaam, which will be used as an approach for future monitoring and surveillance of antimicrobial quantities consumed in food animals. A 3 years (2016-2018) retrospective survey of antimicrobial usage in food-producing animals in three selected districts of Dar es Salaam city, Eastern Tanzania was conducted. Data on antimicrobial quantities consumed was obtained from five purposively selected licensed veterinary pharmaceutical sales/outlet establishments in the study area, based on keeping detailed sales records for the study period. Data analysis was done using IBM SPSS version 20. Animal population data were from FAO-Stat database used to extrapolate the quantity consumed in food animals to the entire population during the study period in Tanzania. The antimicrobials were analysed based on class, importance for human medicine and route of administration. The study revealed that 178.4 tonnes of antimicrobials (by weight of active ingredients) were consumed during the 3 years period, with an average of 59.5 ± 3.8 tonnes/year. The commonly consumed antimicrobials were tetracycline (44.4%), sulphonamides (20.3%), aminoglycosides (10.3%) and beta-lactams (7.4%). In relation to veterinary antimicrobial use importance to human medicine, 34.4% were of critically important antimicrobials; 4.1% reserve and 51% watch group according to AWaRe categorization of WHO. Most of the antimicrobials were administered orally. Overall, a mean of 7.44 ± 0.81 mg/PCU (population correction unit) was consumed by food-producing animals during the 3 years period. This finding can help improve monitoring and control of veterinary antimicrobial use in Dar es Salaam in particular and Tanzania in general by preserving the efficacy of antimicrobials for future animal and human generations.